Life ScienceCompany
Ono Pharmaceutical M&A Summary
Ono Pharmaceutical has acquired 1 company, including 1 in the last 5 years.
Ono Pharmaceutical’s largest acquisition to date was in 2024, when it acquired Deciphera Pharmaceuticals for $2.4B. Ono Pharmaceutical has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
Ono Pharmaceutical Business Overview
Where is Ono Pharmaceutical headquartered?
Ono Pharmaceutical is headquartered in Osaka, Japan.
What sector is Ono Pharmaceutical in?
Ono Pharmaceutical is a life science company.
M&A Summary
-
M&A Total Activity1
- M&A Buy Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Advisors 2